This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$3.6M
Filings
49
Firms Hired
1
Active Period
2015–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act; a bill to amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with metastatic breast cancer, and for other purposes H.R.6280/S.3607- Access to Genetic Counselor Services Act of 2026; a bill to amend title XVIII of the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under part B of the Medicare program, and for other purposes. H.R.4752/S.27060 - Reducing Hereditary Cancer Act; a bill to amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer. Comments in response to Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard (CMS-9874-NC) Comments in response to Medicaid Program; Community Engagement Requirement for Certain Individuals [CMS-2454-IFC] Comments related to Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP [OIG-2602-N; RIN 0936-AA16] Comments related to Medicaid Program; Amending the Indirect Hold Harmless Threshold of Health Care-Related Taxes [CMS-2452-P] Activities related to the implementation of H.R. 1 the One Big Beautiful Bill Act
Client expense: $70,000 · Firm income: —
Matched citations: H.R. 1
Metastatic Breast Cancer Access to Care Act
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act; a bill to amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with metastatic breast cancer, and for other purposes H.R.6280/S.3607- Access to Genetic Counselor Services Act of 2026; a bill to amend title XVIII of the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under part B of the Medicare program, and for other purposes. H.R.4752/S.27060 - Reducing Hereditary Cancer Act; a bill to amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer. Comments in response to Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard (CMS-9874-NC) Comments in response to Medicaid Program; Community Engagement Requirement for Certain Individuals [CMS-2454-IFC] Comments related to Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP [OIG-2602-N; RIN 0936-AA16] Comments related to Medicaid Program; Amending the Indirect Hold Harmless Threshold of Health Care-Related Taxes [CMS-2452-P] Activities related to the implementation of H.R. 1 the One Big Beautiful Bill Act
Client expense: $70,000 · Firm income: —
Matched citations: H.R.2048
SCREENS for Cancer Act of 2025
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.2381/S.1866 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program H.R.4541/S.2339 - The EARLY Act Reauthorization of 2025; a bill to reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009 H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research H.R.3521/S.4440 - Clinical Trial Modernization Act; a bill to modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes Comments related to a proposed rule on Excepted Fertility Benefits (CMS-9879-P) Comments in response to Request for Information: Commonsense Policy Options to Lower Drug Prices for Patients Efforts to introduce legislation related to the establishment of an interagency task force on breast cancer risk assessment tools Efforts related to the Office of Management and Budget Proposed Rule to revise the Guidance for Federal Financial Assistance
Client expense: $70,000 · Firm income: —
Matched citations: H.R.2381
Access to Breast Cancer Diagnosis Act of 2025
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.3037/S.1500 - Access to Breast Cancer Diagnosis Act; a bill to eliminate cost sharing for medically necessary diagnostic and supplemental breast imaging for patients with private insurance H.R.4101/S.5004 - Cancer Drug Parity Act; a bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider
Client expense: $70,000 · Firm income: —
Matched citations: H.R.3037
Clinical Trial Modernization Act
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.2381/S.1866 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program H.R.4541/S.2339 - The EARLY Act Reauthorization of 2025; a bill to reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009 H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research H.R.3521/S.4440 - Clinical Trial Modernization Act; a bill to modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes Comments related to a proposed rule on Excepted Fertility Benefits (CMS-9879-P) Comments in response to Request for Information: Commonsense Policy Options to Lower Drug Prices for Patients Efforts to introduce legislation related to the establishment of an interagency task force on breast cancer risk assessment tools Efforts related to the Office of Management and Budget Proposed Rule to revise the Guidance for Federal Financial Assistance
Client expense: $70,000 · Firm income: —
Matched citations: H.R.3521
Cancer Drug Parity Act of 2025
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.3037/S.1500 - Access to Breast Cancer Diagnosis Act; a bill to eliminate cost sharing for medically necessary diagnostic and supplemental breast imaging for patients with private insurance H.R.4101/S.5004 - Cancer Drug Parity Act; a bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider
Client expense: $70,000 · Firm income: —
Matched citations: H.R.4101
To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.2381/S.1866 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program H.R.4541/S.2339 - The EARLY Act Reauthorization of 2025; a bill to reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009 H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research H.R.3521/S.4440 - Clinical Trial Modernization Act; a bill to modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes Comments related to a proposed rule on Excepted Fertility Benefits (CMS-9879-P) Comments in response to Request for Information: Commonsense Policy Options to Lower Drug Prices for Patients Efforts to introduce legislation related to the establishment of an interagency task force on breast cancer risk assessment tools Efforts related to the Office of Management and Budget Proposed Rule to revise the Guidance for Federal Financial Assistance
Client expense: $70,000 · Firm income: —
Matched citations: H.R.4541
Reducing Hereditary Cancer Act
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act; a bill to amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with metastatic breast cancer, and for other purposes H.R.6280/S.3607- Access to Genetic Counselor Services Act of 2026; a bill to amend title XVIII of the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under part B of the Medicare program, and for other purposes. H.R.4752/S.27060 - Reducing Hereditary Cancer Act; a bill to amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer. Comments in response to Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard (CMS-9874-NC) Comments in response to Medicaid Program; Community Engagement Requirement for Certain Individuals [CMS-2454-IFC] Comments related to Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP [OIG-2602-N; RIN 0936-AA16] Comments related to Medicaid Program; Amending the Indirect Hold Harmless Threshold of Health Care-Related Taxes [CMS-2452-P] Activities related to the implementation of H.R. 1 the One Big Beautiful Bill Act
Client expense: $70,000 · Firm income: —
Matched citations: H.R.4752
Access to Genetic Counselor Services Act of 2025
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act; a bill to amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with metastatic breast cancer, and for other purposes H.R.6280/S.3607- Access to Genetic Counselor Services Act of 2026; a bill to amend title XVIII of the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under part B of the Medicare program, and for other purposes. H.R.4752/S.27060 - Reducing Hereditary Cancer Act; a bill to amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer. Comments in response to Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard (CMS-9874-NC) Comments in response to Medicaid Program; Community Engagement Requirement for Certain Individuals [CMS-2454-IFC] Comments related to Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP [OIG-2602-N; RIN 0936-AA16] Comments related to Medicaid Program; Amending the Indirect Hold Harmless Threshold of Health Care-Related Taxes [CMS-2452-P] Activities related to the implementation of H.R. 1 the One Big Beautiful Bill Act
Client expense: $70,000 · Firm income: —
Matched citations: H.R.6280
Breast Cancer Research Stamp Reauthorization Act of 2026
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research.
Client expense: $70,000 · Firm income: —
Matched citations: H.R.8358
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; a bill making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2027, and for other purposes H.R.9495 - Department of Defense Appropriations Act, 2027; a bill making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; a bill making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9770 - Continuing Appropriations Act, 2027; a bill to provide continuing FY2027 appropriations for federal agencies and extends various expiring programs and authorities FY27 appropriations related to funding for biomedical research, National Breast and Cervical Cancer Early Detection Program, cancer prevention and control, FDA funding, and related cancer services Comments related to Regulation for Federal Financial Assistance (OMB-2026-0034)
Client expense: $70,000 · Firm income: —
Matched citations: H.R.8646
National Defense Authorization Act for Fiscal Year 2027
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.8800/ S.4784 - National Defense Authorization Act for Fiscal Year 2027; a bill to set forth policies and authorities for FY2027 for Department of Defense (DOD) programs, activities, and military construction as well as the national security programs of the Department of Energy (DOE).
Client expense: $70,000 · Firm income: —
Matched citations: H.R.8800
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; a bill making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2027, and for other purposes H.R.9495 - Department of Defense Appropriations Act, 2027; a bill making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; a bill making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9770 - Continuing Appropriations Act, 2027; a bill to provide continuing FY2027 appropriations for federal agencies and extends various expiring programs and authorities FY27 appropriations related to funding for biomedical research, National Breast and Cervical Cancer Early Detection Program, cancer prevention and control, FDA funding, and related cancer services Comments related to Regulation for Federal Financial Assistance (OMB-2026-0034)
Client expense: $70,000 · Firm income: —
Matched citations: H.R.9260
Department of Defense Appropriations Act, 2027
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; a bill making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2027, and for other purposes H.R.9495 - Department of Defense Appropriations Act, 2027; a bill making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; a bill making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9770 - Continuing Appropriations Act, 2027; a bill to provide continuing FY2027 appropriations for federal agencies and extends various expiring programs and authorities FY27 appropriations related to funding for biomedical research, National Breast and Cervical Cancer Early Detection Program, cancer prevention and control, FDA funding, and related cancer services Comments related to Regulation for Federal Financial Assistance (OMB-2026-0034)
Client expense: $70,000 · Firm income: —
Matched citations: H.R.9495
Continuing Appropriations Act, 2027
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; a bill making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2027, and for other purposes H.R.9495 - Department of Defense Appropriations Act, 2027; a bill making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; a bill making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9770 - Continuing Appropriations Act, 2027; a bill to provide continuing FY2027 appropriations for federal agencies and extends various expiring programs and authorities FY27 appropriations related to funding for biomedical research, National Breast and Cervical Cancer Early Detection Program, cancer prevention and control, FDA funding, and related cancer services Comments related to Regulation for Federal Financial Assistance (OMB-2026-0034)
Client expense: $70,000 · Firm income: —
Matched citations: H.R.9770
Access to Breast Cancer Diagnosis Act of 2025
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.3037/S.1500 - Access to Breast Cancer Diagnosis Act; a bill to eliminate cost sharing for medically necessary diagnostic and supplemental breast imaging for patients with private insurance H.R.4101/S.5004 - Cancer Drug Parity Act; a bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider
Client expense: $70,000 · Firm income: —
Matched citations: S.1500
SCREENS for Cancer Act of 2025
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.2381/S.1866 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program H.R.4541/S.2339 - The EARLY Act Reauthorization of 2025; a bill to reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009 H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research H.R.3521/S.4440 - Clinical Trial Modernization Act; a bill to modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes Comments related to a proposed rule on Excepted Fertility Benefits (CMS-9879-P) Comments in response to Request for Information: Commonsense Policy Options to Lower Drug Prices for Patients Efforts to introduce legislation related to the establishment of an interagency task force on breast cancer risk assessment tools Efforts related to the Office of Management and Budget Proposed Rule to revise the Guidance for Federal Financial Assistance
Client expense: $70,000 · Firm income: —
Matched citations: S.1866
EARLY Act Reauthorization of 2025
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.2381/S.1866 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program H.R.4541/S.2339 - The EARLY Act Reauthorization of 2025; a bill to reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009 H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research H.R.3521/S.4440 - Clinical Trial Modernization Act; a bill to modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes Comments related to a proposed rule on Excepted Fertility Benefits (CMS-9879-P) Comments in response to Request for Information: Commonsense Policy Options to Lower Drug Prices for Patients Efforts to introduce legislation related to the establishment of an interagency task force on breast cancer risk assessment tools Efforts related to the Office of Management and Budget Proposed Rule to revise the Guidance for Federal Financial Assistance
Client expense: $70,000 · Firm income: —
Matched citations: S.2339
Metastatic Breast Cancer Access to Care Act
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act; a bill to amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with metastatic breast cancer, and for other purposes H.R.6280/S.3607- Access to Genetic Counselor Services Act of 2026; a bill to amend title XVIII of the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under part B of the Medicare program, and for other purposes. H.R.4752/S.27060 - Reducing Hereditary Cancer Act; a bill to amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer. Comments in response to Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard (CMS-9874-NC) Comments in response to Medicaid Program; Community Engagement Requirement for Certain Individuals [CMS-2454-IFC] Comments related to Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP [OIG-2602-N; RIN 0936-AA16] Comments related to Medicaid Program; Amending the Indirect Hold Harmless Threshold of Health Care-Related Taxes [CMS-2452-P] Activities related to the implementation of H.R. 1 the One Big Beautiful Bill Act
Client expense: $70,000 · Firm income: —
Matched citations: S.3442
Access to Genetic Counselor Services Act of 2026
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act; a bill to amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with metastatic breast cancer, and for other purposes H.R.6280/S.3607- Access to Genetic Counselor Services Act of 2026; a bill to amend title XVIII of the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under part B of the Medicare program, and for other purposes. H.R.4752/S.27060 - Reducing Hereditary Cancer Act; a bill to amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer. Comments in response to Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard (CMS-9874-NC) Comments in response to Medicaid Program; Community Engagement Requirement for Certain Individuals [CMS-2454-IFC] Comments related to Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP [OIG-2602-N; RIN 0936-AA16] Comments related to Medicaid Program; Amending the Indirect Hold Harmless Threshold of Health Care-Related Taxes [CMS-2452-P] Activities related to the implementation of H.R. 1 the One Big Beautiful Bill Act
Client expense: $70,000 · Firm income: —
Matched citations: S.3607
Breast Cancer Stamp Reauthorization Act
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research.
Client expense: $70,000 · Firm income: —
Matched citations: S.4318
Clinical Trial Modernization Act
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.2381/S.1866 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program H.R.4541/S.2339 - The EARLY Act Reauthorization of 2025; a bill to reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009 H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research H.R.3521/S.4440 - Clinical Trial Modernization Act; a bill to modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes Comments related to a proposed rule on Excepted Fertility Benefits (CMS-9879-P) Comments in response to Request for Information: Commonsense Policy Options to Lower Drug Prices for Patients Efforts to introduce legislation related to the establishment of an interagency task force on breast cancer risk assessment tools Efforts related to the Office of Management and Budget Proposed Rule to revise the Guidance for Federal Financial Assistance
Client expense: $70,000 · Firm income: —
Matched citations: S.4440
National Defense Authorization Act for Fiscal Year 2027
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.8800/ S.4784 - National Defense Authorization Act for Fiscal Year 2027; a bill to set forth policies and authorities for FY2027 for Department of Defense (DOD) programs, activities, and military construction as well as the national security programs of the Department of Energy (DOE).
Client expense: $70,000 · Firm income: —
Matched citations: S.4784
Cancer Drug Parity Act of 2026
2026 · third_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.3037/S.1500 - Access to Breast Cancer Diagnosis Act; a bill to eliminate cost sharing for medically necessary diagnostic and supplemental breast imaging for patients with private insurance H.R.4101/S.5004 - Cancer Drug Parity Act; a bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider
Client expense: $70,000 · Firm income: —
Matched citations: S.5004
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · second_quarter · Firm: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act; a bill to amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with metastatic breast cancer, and for other purposes H.R.6280/S.3607- Access to Genetic Counselor Services Act of 2026; a bill to amend title XVIII of the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under part B of the Medicare program, and for other purposes. H.R.4752/S.27060 - Reducing Hereditary Cancer Act; a bill to amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer. Comments in response to Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges (CMS-0062-P) Activities related to the implementation of H.R. 1 the One Big Beautiful Bill Act
Client expense: $130,000 · Firm income: —
Matched citations: H.R. 1
Source: Senate LDA